nach oben

Current Neurology and Neuroscience Reports

Erschienen in:

01.12.2019 | Critical Care (Stephan A. Mayer, Section Editor)

Management of Elevated Intracranial Pressure: a Review

verfasst von: Abhinav R. Changa, Barry M. Czeisler, Aaron S. Lord

Erschienen in: Current Neurology and Neuroscience Reports | Ausgabe 12/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Principles of intracranial pressure (ICP) management continue to be an essential part of the neurointensivist’s skillset as appropriate treatment decisions can prevent secondary injury to the central nervous system. This review of the literature aims to: discuss commonly encountered pathologies associated with increased ICP, summarize diagnostic approaches used in evaluating ICP, and present evidence-based treatment paradigms that drive clinical care in intensive care units.

Recent Findings

Recent topics of discussion include invasive and non-invasive modalities of diagnosis and monitoring, recent developments in hypothermia, hyperosmolar therapy, pharmacological interventions, and surgical therapies. The authors also present an example of an algorithm used within our system of hospitals for managing patients with elevated ICP.

Summary

Recent advances have shown the mortality benefits in appropriately recognizing and treating increased ICP. Multiple modalities of treatment have been explored, and evidence has shown benefit in some. Further work continues to provide clarity in the appropriate management of intracranial hypertension.

Chesnut RM, Temkin N, Carney N, et al. A trial of intracranial-pressure monitoring in traumatic brain injury. N Engl J Med. 2012;367:2471–81. https://doi.org/10.1056/NEJMoa1207363.CrossRefPubMedPubMedCentral

Ropper AH. Brain in a box. N Engl J Med. 2012;367:2539–41. https://doi.org/10.1056/NEJMe1212289.CrossRefPubMed

Bales JW, Bonow RH, Buckley RT, Barber J, Temkin N, Chesnut RM. Primary external ventricular drainage catheter versus intraparenchymal icp monitoring: outcome analysis. Neurocrit Care. 2019;31:11–21. https://doi.org/10.1007/s12028-019-00712-9.CrossRefPubMed

Aiolfi A, Khor D, Cho J, Benjamin E, Inaba K, Demetriades D. Intracranial pressure monitoring in severe blunt head trauma: does the type of monitoring device matter? J Neurosurg. 2018;128:828–33. https://doi.org/10.3171/2016.11.JNS162198.CrossRefPubMed

Liu H, Wang W, Cheng F, Yuan Q, Yang J, Hu J, et al. External ventricular drains versus intraparenchymal intracranial pressure monitors in traumatic brain injury: a prospective observational study. World Neurosurg. 2015;83:794–800. https://doi.org/10.1016/j.wneu.2014.12.040.CrossRefPubMed

Tavakoli S, Peitz G, Ares W, et al. Complications of invasive intracranial pressure monitoring devices in neurocritical care. Neurosurg Focus. 2017;43:E6. https://doi.org/10.3171/2017.8.FOCUS17450.CrossRefPubMed

Rajajee V, Vanaman M, Fletcher JJ, Jacobs TL. Optic nerve ultrasound for the detection of raised intracranial pressure. Neurocrit Care. 2011;15:506–15. https://doi.org/10.1007/s12028-011-9606-8.CrossRefPubMed

Rosenberg JB, Shiloh AL, Savel RH, Eisen LA. Non-invasive methods of estimating intracranial pressure. Neurocrit Care. 2011;15:599–608. https://doi.org/10.1007/s12028-011-9545-4.CrossRefPubMed

Kim SE, Hong EP, Kim HC, et al. Ultrasonographic optic nerve sheath diameter to detect increased intracranial pressure in adults: a meta-analysis. Acta Radiol. 2019;60:221–9. https://doi.org/10.1177/0284185118776501.CrossRefPubMed

10.

• Robba C, Santori G, Czosnyka M, et al. Optic nerve sheath diameter measured sonographically as non-invasive estimator of intracranial pressure: a systematic review and meta-analysis. Intensive Care Med. 2018;44:1284–94. https://doi.org/10.1007/s00134-018-5305-7 This study was a meta-analysis looking at multiple studies, and they showed that there is utility in using ONSD as a means of detecting increased ICP in a present versus absent fashion. CrossRefPubMed

11.

del Saz-Saucedo P, Redondo-Gonzalez O, Mateu-Mateu A, et al. Sonographic assessment of the optic nerve sheath diameter in the diagnosis of idiopathic intracranial hypertension. J Neurol Sci. 2016;361:122–7. https://doi.org/10.1016/j.jns.2015.12.032.CrossRefPubMed

12.

Agrawal A, Cheng R, Tang J, Madhok DY. Comparison of two techniques to measure optic nerve sheath diameter in patients at risk for increased intracranial pressure. Crit Care Med. 2019;47:e495–501. https://doi.org/10.1097/CCM.0000000000003742.CrossRefPubMedPubMedCentral

13.

Du J, Deng Y, Li H, et al. Ratio of optic nerve sheath diameter to eyeball transverse diameter by ultrasound can predict intracranial hypertension in traumatic brain injury patients: a prospective study. Neurocrit Care. 2019. https://doi.org/10.1007/s12028-019-00762-z.

14.

Vaiman M, Sigal T, Kimiagar I, et al. Noninvasive assessment of the intracranial pressure in non-traumatic intracranial hemorrhage. J Clin Neurosci. 2016;34:177–81. https://doi.org/10.1016/j.jocn.2016.06.008.CrossRefPubMed

15.

Rajajee V, Williamson CA, Fontana RJ, Courey AJ, Patil PG. Noninvasive intracranial pressure assessment in acute liver failure. Neurocrit Care. 2018;29:280–90. https://doi.org/10.1007/s12028-018-0540-x.CrossRefPubMed

16.

Czosnyka M, Matta BF, Smielewski P, et al. Cerebral perfusion pressure in head-injured patients: a noninvasive assessment using transcranial Doppler ultrasonography. J Neurosurg. 1998;88:802–8. https://doi.org/10.3171/jns.1998.88.5.0802.CrossRefPubMed

17.

Robba C, Cardim D, Sekhon M, Budohoski K, Czosnyka M. Transcranial Doppler: a stethoscope for the brain-neurocritical care use. J Neurosci Res. 2018;96:720–30. https://doi.org/10.1002/jnr.24148.CrossRefPubMed

18.

Robba C, Donnelly J, Cardim D, Tajsic T, Cabeleira M, Citerio G, et al. Optic nerve sheath diameter ultrasonography at admission as a predictor of intracranial hypertension in traumatic brain injured patients: a prospective observational study. J Neurosurg. 2019:1–7. https://doi.org/10.3171/2018.11.JNS182077.

19.

Chen JW, Gombart ZJ, Rogers S, Gardiner SK, Cecil S, Bullock RM. Pupillary reactivity as an early indicator of increased intracranial pressure: The introduction of the Neurological Pupil index. Surg Neurol Int. 2011;2:82. https://doi.org/10.4103/2152-7806.82248.CrossRefPubMedPubMedCentral

20.

Ong C, Hutch M, Barra M, Kim A, Zafar S, Smirnakis S. Effects of osmotic therapy on pupil reactivity: quantification using pupillometry in critically ill neurologic patients. Neurocrit Care. 2019;30:307–15. https://doi.org/10.1007/s12028-018-0620-y.CrossRefPubMed

21.

Jahns FP, Miroz JP, Messerer M, Daniel RT, Taccone FS, Eckert P, et al. Quantitative pupillometry for the monitoring of intracranial hypertension in patients with severe traumatic brain injury. Crit Care. 2019;23:155. https://doi.org/10.1186/s13054-019-2436-3.

22.

Newey CR, Sarwal A, Hantus S. Continuous electroencephalography (cEEG) changes precede clinical changes in a case of progressive cerebral edema. Neurocrit Care. 2013;18:261–5. https://doi.org/10.1007/s12028-011-9650-4.CrossRefPubMed

23.

Kurtz P, Hanafy KA, Claassen J. Continuous EEG monitoring: is it ready for prime time? Curr Opin Crit Care. 2009;15:99–109. https://doi.org/10.1097/MCC.0b013e3283294947.CrossRefPubMed

24.

Hartings JA, Strong AJ, Fabricius M, Manning A, Bhatia R, Dreier JP, et al. Spreading depolarizations and late secondary insults after traumatic brain injury. J Neurotrauma. 2009;26:1857–66. https://doi.org/10.1089/neu.2009.0961.CrossRefPubMedPubMedCentral

25.

Brain Trauma F, American Association of Neurological S, Congress of Neurological S, et al. Guidelines for the management of severe traumatic brain injury. II. Hyperosmolar therapy. J Neurotrauma. 2007;24(Suppl 1):S14–20. https://doi.org/10.1089/neu.2007.9994.CrossRef

26.

Farrokh S, Cho SM, Suarez JI. Fluids and hyperosmolar agents in neurocritical care: an update. Curr Opin Crit Care. 2019;25:105–9. https://doi.org/10.1097/MCC.0000000000000585.CrossRefPubMed

27.

Diringer MN. New trends in hyperosmolar therapy? Curr Opin Crit Care. 2013;19:77–82. https://doi.org/10.1097/MCC.0b013e32835eba30.CrossRefPubMedPubMedCentral

28.

Rangel-Castilla L, Gopinath S, Robertson CS. Management of intracranial hypertension. Neurol Clin. 2008;26:521–41, x. https://doi.org/10.1016/j.ncl.2008.02.003.CrossRefPubMed

29.

Gu J, Huang H, Huang Y, Sun H, Xu H. Hypertonic saline or mannitol for treating elevated intracranial pressure in traumatic brain injury: a meta-analysis of randomized controlled trials. Neurosurg Rev. 2019;42:499–509. https://doi.org/10.1007/s10143-018-0991-8.CrossRefPubMed

30.

Mangat HS, Chiu YL, Gerber LM, Alimi M, Ghajar J, Härtl R. Hypertonic saline reduces cumulative and daily intracranial pressure burdens after severe traumatic brain injury. J Neurosurg. 2015;122:202–10. https://doi.org/10.3171/2014.10.JNS132545.CrossRefPubMed

31.

•• Mangat HS, Wu X, Gerber LM, et al. Hypertonic saline is superior to mannitol for the combined effect on intracranial pressure and cerebral perfusion pressure burdens in patients with severe traumatic brain injury. Neurosurgery. 2019. https://doi.org/10.1093/neuros/nyz046 This study utilized a TBI cohort to assess for differences in the degree of increased ICP, decreased CPP, and the degree of their concomittance when administered either hypertonic saline or mannitol; the study showed hypertonic saline superiority in decreasing the cumulative burden of concomitant increased ICP with decreased CPP.

32.

King ZA, Sheth KN, Kimberly WT, Simard JM. Profile of intravenous glyburide for the prevention of cerebral edema following large hemispheric infarction: evidence to date. Drug Des Devel Ther. 2018;12:2539–52. https://doi.org/10.2147/DDDT.S150043.CrossRefPubMedPubMedCentral

33.

Simard JM, Sheth KN, Kimberly WT, Stern BJ, del Zoppo G, Jacobson S, et al. Glibenclamide in cerebral ischemia and stroke. Neurocrit Care. 2014;20:319–33. https://doi.org/10.1007/s12028-013-9923-1.CrossRef

34.

Sheth KN, Elm JJ, Molyneaux BJ, et al. Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Neurol. 2016;15:1160–9. https://doi.org/10.1016/S1474-4422(16)30196-X.CrossRefPubMed

35.••

Kimberly WT, Bevers MB, von Kummer R, Demchuk AM, Romero JM, Elm JJ, et al. Effect of IV glyburide on adjudicated edema endpoints in the GAMES-RP Trial. Neurology. 2018;91:e2163–9. https://doi.org/10.1212/WNL.0000000000006618 This study analyzed the GAMES-RP trial results to show that IV glyburide administration within 10 h of symptoms onset in anterior circulation strokes with large infarct volumes showed benefit in reducing the rate of cerebral edema-related deaths. CrossRefPubMedPubMedCentral

36.

Sheth KN, Petersen NH, Cheung K, Elm JJ, Hinson HE, Molyneaux BJ, et al. Long-term outcomes in patients aged </=70 years with intravenous glyburide from the phase II GAMES-RP study of large hemispheric infarction: an exploratory analysis. Stroke. 2018;49:1457–63. https://doi.org/10.1161/STROKEAHA.117.020365.CrossRefPubMedPubMedCentral

37.

Galicich JH, French LA, Melby JC. Use of dexamethasone in treatment of cerebral edema associated with brain tumors. J Lancet. 1961;81:46–53.PubMed

38.

Kaal EC, Vecht CJ. The management of brain edema in brain tumors. Curr Opin Oncol. 2004;16:593–600.CrossRefPubMed

39.

Ly KI, Wen PY. Clinical relevance of steroid use in neuro-oncology. Curr Neurol Neurosci Rep. 2017;17:5. https://doi.org/10.1007/s11910-017-0713-6.CrossRefPubMed

40.

Roth P, Happold C, Weller M. Corticosteroid use in neuro-oncology: an update. Neurooncol Pract. 2015;2:6–12. https://doi.org/10.1093/nop/npu029.CrossRefPubMed

41.

Roberts I, Yates D, Sandercock P, Farrell B, Wasserberg J, Lomas G, et al. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet. 2004;364:1321–8. https://doi.org/10.1016/S0140-6736(04)17188-2.

42.

Edwards P, Arango M, Balica L, Cottingham R, el-Sayed H, Farrell B, et al. Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months. Lancet. 2005;365:1957–9. https://doi.org/10.1016/S0140-6736(05)66552-X.

43.

Clifton GL, Valadka A, Zygun D, Coffey CS, Drever P, Fourwinds S, et al. Very early hypothermia induction in patients with severe brain injury (the National Acute Brain Injury Study: Hypothermia II): a randomised trial. Lancet Neurol. 2011;10:131–9. https://doi.org/10.1016/S1474-4422(10)70300-8.CrossRefPubMed

44.

•• Cooper DJ, Nichol AD, Bailey M, Bernard S, Cameron PA, Pili-Floury S, et al. Effect of early sustained prophylactic hypothermia on neurologic outcomes among patients with severe traumatic brain injury: the POLAR randomized clinical trial. JAMA. 2018;320:2211–20. https://doi.org/10.1001/jama.2018.17075 The POLAR study was a randomized controlled trial that tested the efficacy of prophylactic hypothermia in the setting of TBI; the study showed that there was no significant difference in favorable outcome rates at 6 months when comparing patients that underwent normothermia protocol versus patients that underwent prophylactic hypothermia. CrossRefPubMedPubMedCentral

45.

Andrews PJ, Sinclair HL, Rodriguez A, Harris BA, Battison CG, Rhodes JK, et al. Hypothermia for intracranial hypertension after traumatic brain injury. N Engl J Med. 2015;373:2403–12. https://doi.org/10.1056/NEJMoa1507581.CrossRef

46.

Hutchinson PJ, Kolias AG, Timofeev IS, Corteen EA, Czosnyka M, Timothy J, et al. Trial of decompressive craniectomy for traumatic intracranial hypertension. N Engl J Med. 2016;375:1119–30. https://doi.org/10.1056/NEJMoa1605215.CrossRef

47.

Cooper DJ, Rosenfeld JV, Murray L, et al. Decompressive craniectomy in diffuse traumatic brain injury. N Engl J Med. 2011;364:1493–502. https://doi.org/10.1056/NEJMoa1102077.CrossRefPubMed

48.

Shutter LA, Timmons SD. Intracranial pressure rescued by decompressive surgery after traumatic brain injury. N Engl J Med. 2016;375:1183–4. https://doi.org/10.1056/NEJMe1609722.CrossRefPubMed

49.

• Ziai WC, Thompson CB, Mayo S, McBee N, Freeman WD, Dlugash R, et al. Intracranial hypertension and cerebral perfusion pressure insults in adult hypertensive intraventricular hemorrhage: occurrence and associations with outcome. Crit Care Med. 2019;47:1125–34. https://doi.org/10.1097/CCM.0000000000003848 This study utilized CLEAR III trial data to show ICP values as low as 18 mmHg can be associated with worsened mortality in older patients and that age may affect ICP thresholds. It also highlighted the relationship between ICP and CPP, calling for investigation in merging the two parameters in management protocols. CrossRefPubMed

50.

Hanley DF, Lane K, McBee N, Ziai W, Tuhrim S, Lees KR, et al. Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial. Lancet. 2017;389:603–11. https://doi.org/10.1016/S0140-6736(16)32410-2.CrossRef

Titel: Management of Elevated Intracranial Pressure: a Review
verfasst von: Abhinav R. Changa
Barry M. Czeisler
Aaron S. Lord
Publikationsdatum: 01.12.2019
Verlag: Springer US
Erschienen in: Current Neurology and Neuroscience Reports / Ausgabe 12/2019
Print ISSN: 1528-4042
Elektronische ISSN: 1534-6293
DOI: https://doi.org/10.1007/s11910-019-1010-3

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2019

Inflammatory Disorders of the Skull Base: a Review

Can Salient Stimuli Enhance Responses in Disorders of Consciousness? A Systematic Review

Neurological Manifestations of Achondroplasia

Neuroimaging in Vascular Parkinsonism

Sherpas, Coca Leaves, and Planes: High Altitude and Airplane Headache Review with a Case of Post-LASIK Myopic Shift